Race Oncology looks to accelerate clinical development of bisantrene

By Proactive Investors / February 28, 2024 / www.youtube.com / Article Link

Race Oncology Ltd (ASX:RAC) CEO Daniel Tillett joins Jonathan Jackson in the Proactive studio to provide an update on the ...

Recent News

Equity highs and low credit spreads may be warning signs

August 10, 2026 / www.canadianminingreport.com

Gold stocks see strongest week in a decade

August 10, 2026 / www.canadianminingreport.com

Big Gold's strong Q2/26 results continue

August 03, 2026 / www.canadianminingreport.com

Gold stocks see moderate declines

August 03, 2026 / www.canadianminingreport.com

Market still expecting strong growth for major gold producers

July 27, 2026 / www.canadianminingreport.com

See all >